Mark Turco

Dr. Turco spent 7 years working for large cap medical device companies, serving as Vice President and Chief Medical Officer of the vascular and neuro franchises for Medtronic, Inc. and Covidien, plc. In these roles, he informed strategy for complex business decisions regarding technologies and programs. He evaluated opportunities for growth and investment and was integral to the evaluation of new business development prospects. Dr. Turco was instrumental in helping to build out Covidien’s vascular platform, which was subsequently a key component of Medtronic’s acquisition of Covidien.

After receiving an undergraduate degree from the University of Pennsylvania, Dr. Turco received his medical degree and internal medicine training at the George Washington University in Washington, D.C. and performed his cardiology training at Temple University Hospital and at Penn-Presbyterian Medical Center in Philadelphia. He practiced as an interventional cardiologist in the Washington, D.C. area for 16 years, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital and maintained an active patient care practice across all fields of cardiovascular disease. Keys areas of academic interest and research were in the fields of cardiac arrest and cardiogenic shock, acute myocardial infarction, drug device delivery, embolic protection and structural and valvular heart disease. As a practicing cardiologist, Dr. Turco also played a role in the development from concept to commercialization of several medical devices currently being utilized in the field of cardiovascular medicine.